Ammonia Detection in Dialysis Systems
The ammonia concentration in the dialysate is monitored in real time through the spectral detection system, and the reflectance ratio and moving average technology are used to solve the ammonia accumulation problem caused by ammonium leakage in the adsorbent box, improving the accuracy and safety of dialysis treatment.
Patent Information
- Application Number
- CN202080058117.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-06-11
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-06-11
AI Technical Summary
Ammonium leakage in adsorbent cartridges in the dialysis system causes ammonia accumulation in the dialysate, affecting the treatment effect, and it is difficult for the prior art to effectively monitor and adjust.
Using spectral detection system, including sensors and detectors, the excessive ammonia in the dialysate is identified through the reflectance ratio, the acid-base indicator and LED light source are used, combined with moving average technology and slope analysis, to monitor and alert the ammonia concentration exceeding the limit in real time .
It improves the accuracy and real-time performance of ammonia detection in dialysate, avoids false alarms caused by temperature changes and noise, and ensures the safety and effectiveness of dialysis treatment.
Smart Images

Figure CN114270170B_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to a fluid regulating system for generating and regulating a dialysis fluid used by a dialysis machine to perform a dialysis treatment. Such a fluid regulating system may include a mechanism for detecting ammonia within the dialysis fluid. Background Art
[0002] Dialysis is a medical treatment method that provides life-saving support for patients with renal insufficiency. Two main dialysis methods are hemodialysis (HD) and peritoneal dialysis (PD). During HD, the patient's blood passes through the dialyzer of the dialysis machine, and the dialysis solution (or dialysate) also usually passes through the dialyzer in the reverse or countercurrent direction. The semipermeable membrane in the dialyzer separates the blood from the dialysate, and allows fluid exchange to occur between the dialysate and the blood flow via diffusion, osmosis and convection flow. These exchanges across the membrane remove waste (e.g., solutes such as urea and creatinine) from the blood. These exchanges also help regulate the level of other substances (e.g., sodium and water) in the blood. In this way, the dialyzer and the dialysis machine can serve as an artificial kidney for purifying blood.
[0003] During PD, the patient's peritoneal cavity is regularly infused with dialysate. The membranous lining of the patient's peritoneum acts as a natural semipermeable membrane, allowing diffusion and osmotic exchange between the solution in the peritoneal cavity and the bloodstream. Like HD, these exchanges across the patient's peritoneum remove waste products from the blood and help regulate the levels of other substances in the blood (e.g., sodium and water).
[0004] Some dialysis systems also include a sorbent cartridge for regenerating (e.g., recycling) the dialysate, significantly reducing the amount of dialysate required to achieve a complete treatment session. The sorbent cartridge can be designed to remove ammonium from the dialysate. However, the ability of such a cartridge to adsorb ammonium can diminish over time, such that undesirable amounts of ammonium and ammonia may accumulate in the dialysate. Summary of the invention
[0005] The present disclosure relates to a fluid regulating system for generating and regulating a dialysis fluid used by a dialysis machine to perform a dialysis treatment. In some embodiments, the fluid regulating system includes an ammonia detection system implemented as a spectroscopic detection system for monitoring the amount of ammonia in the dialysis fluid circulating within the fluid regulating system. The amount of ammonia in the dialysis fluid reflects the extent of ammonium leakage into the dialysis fluid as the dialysis fluid circulates through a sorbent cartridge of the fluid regulating system.
[0006] In one aspect, a spectral detection system includes a sensor configured to reflect light of a first wavelength associated with the presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with the presence of a monitored substance on the sensor, wherein the monitored substance flows from a circulating fluid to the sensor. The spectral detection system also includes a detector having first and second channels for receiving the first and second wavelengths of light reflected from the sensor, respectively, and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance relative to the circulating fluid based on a ratio of a second amount of light of the second wavelength received at the detector to a first amount of light of the first wavelength received at the detector.
[0007] Implementations may include one or more of the following features.
[0008] In some embodiments, the sensor includes an acid-base indicator that is sensitive to the pH value of the monitored substance.
[0009] In certain embodiments, the reference substance is an acidic substance, wherein, in an initial state where the reference substance is present on the sensor and the monitored substance is not present on the sensor, the sensor is a first color, and wherein, in a subsequent state where both the reference substance and the monitored substance are present on the sensor, the sensor is a second color.
[0010] In some embodiments, the spectral detection system further comprises one or more lenses arranged to focus the first and second wavelengths of light reflected from the sensor onto the detector.
[0011] In some embodiments, the spectral detection system further comprises an LED configured to radiate broadband light onto a sensor, wherein the sensor is configured to reflect a first portion of the broadband light as light of a first wavelength and a second portion of the broadband light as light of a second wavelength.
[0012] In some embodiments, the spectroscopic detection system further comprises a membrane that is permeable to the substance being monitored and is positioned upstream of the sensor.
[0013] In some embodiments, the spectral detection system further includes a housing supporting the sensor and configured to absorb ambient light.
[0014] In some embodiments, the sensor is oriented parallel to the bulk flow direction of the circulating fluid and perpendicular to the flow of the monitored substance toward the sensor.
[0015] In certain embodiments, the spectral detection system further includes a flow obstacle oriented perpendicular to the bulk flow direction of the circulating fluid and generating a disturbance in the bulk flow of the circulating fluid.
[0016] In some embodiments, the flow obstruction is configured to increase the velocity of the volume flow of the circulating fluid.
[0017] In some embodiments, the sensor includes a paper material.
[0018] In some embodiments, the spectroscopic detection system further comprises a connector body housing the sensor and configured to be assembled with a fluid line of a fluid box, wherein the connector body is arranged to receive a volume flow of the circulating fluid from a device configured to remove a precursor chemical of a monitored substance from the circulating fluid.
[0019] In some embodiments, the first amount of light at the first wavelength includes a first percentage reflectance of a first color associated with the first wavelength of light, and the second amount of light at the second wavelength includes a second percentage reflectance of a second color associated with the second wavelength of light.
[0020] In some embodiments, the overdose condition comprises an increase in the concentration of the monitored substance within the circulating fluid, and the increase in the concentration of the monitored substance corresponds to an increase in the concentration of a precursor chemical of the monitored substance to a value approximately equal to or greater than a threshold concentration of the precursor chemical.
[0021] In certain embodiments, the one or more processors are configured to identify the overdose condition by determining a moving average of the ratio.
[0022] In some embodiments, the one or more processors are configured to identify an overdose condition by determining a rate of change of the ratio.
[0023] In certain embodiments, the one or more processors are configured to identify an overdose condition by comparing a moving average of the ratio to one or more criteria.
[0024] In some embodiments, the one or more processors are configured to transmit data associated with triggering an alarm notification when an overdose condition is identified.
[0025] In some embodiments, the sensor is disposable and the detector is reusable.
[0026] In some embodiments, the circulating fluid is dialysate and the monitored substance is ammonia.
[0027] In another aspect, a dialysis system includes a sorbent cartridge configured to remove a precursor substance from a dialysate circulating through the dialysis system, wherein the precursor substance is a precursor of a monitored substance, and the dialysis system further includes a spectral detection system for identifying an excess condition of the monitored substance relative to the dialysate. The spectral detection system includes a sensor configured to reflect light of a first wavelength associated with the presence of a reference substance on the sensor, and configured to reflect light of a second wavelength associated with the presence of a monitored substance on the sensor, wherein the monitored substance flows from the dialysate to the sensor. The spectral detection system also includes a detector having first and second channels for receiving the first and second wavelengths of light reflected from the sensor, respectively, and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance relative to the circulating fluid based on a ratio of a second amount of light of the second wavelength received at the detector to a first amount of light of the first wavelength received at the detector.
[0028] In another aspect, a method of detecting a monitored substance in a circulating fluid includes flowing the monitored substance from the circulating fluid to a sensor, reflecting light of a first wavelength from the sensor based on the presence of a reference substance on the sensor, and reflecting light of a second wavelength from the sensor based on the presence of the monitored substance on the sensor, receiving the first and second wavelengths of light reflected from the sensor in first and second channels of the detector, respectively, and identifying, at one or more processors in electrical communication with the detector, an excess condition of the monitored substance relative to the circulating fluid based on a ratio of a second amount of light of the second wavelength received at the detector to a first amount of light of the first wavelength received at the detector.
[0029] Embodiments may provide one or more of the following advantages.
[0030] In some embodiments, analyzing the reflectance at the sensor as a ratio of blue and red intensities is used to amplify the detection of ammonia in the circulating dialysate, as compared to analyzing the reflectance at the sensor as independent, separate absolute values of blue and red intensities according to conventional reflectance spectroscopy techniques for ammonia detection. For example, both the numerator and denominator of the reflectance ratio can be varied, whereas conventional techniques only consider the absolute value of the blue intensity or the absolute value of the red intensity of light reflected from the ammonium sensor. Therefore, examining the reflectance as a ratio can avoid false alarm conditions that may be observed during the stage when the dialysate is heated to physiological temperature due to temperature-related changes in the reflectance spectrum using conventional techniques. In some examples, a moving average technique is applied to the reflectance ratio data to advantageously smooth the curve of the percentage reflectance ratio, thereby minimizing the effects due to noise factors.
[0031] In some examples, undesirable effects of natural variations on the absolute value of the percent reflectivity ratio can be accounted for by examining the rate of change of the percent reflectivity ratio. For example, in a slope analysis of the percent reflectivity ratio, such undesirable effects (e.g., temperature-related effects) and various noise factors may have shorter durations than in the absolute value of the percent reflectivity ratio. Additionally, events such as lens fogging may also last for shorter periods of time in a slope analysis.
[0032] Other aspects, features, and advantages will be apparent from the description, drawings, and claims herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 is a perspective view of a fluid regulation system that may cooperate with a dialysis system to perform a fluid regulation cycle including a dialysis treatment.
[0034] Figure 2 yes Figure 1 A top view of a fluid regulating system.
[0035] Figure 3 yes Figure 1 Front view of the fluid regulating system.
[0036] Figure 4 yes Figure 1 Rear view of the fluid regulation system.
[0037] Figure 5 yes Figure 1 A rear view of a fluid regulating system with certain exterior components omitted to expose certain interior components.
[0038] Figure 6 yes Figure 1 A perspective view of a fluid regulating system with certain exterior components omitted to expose certain interior components.
[0039] Figure 7 yes Figure 1 A perspective view of a fluid regulating system with certain exterior components omitted to expose certain interior components.
[0040] Figure 8 yes Figure 1 A perspective view of a fluid regulating system with certain exterior components omitted to expose certain interior components.
[0041] Fig. 9 yes Figure 1 A perspective view of the front assembly of a fluid regulating system.
[0042] Fig.10 yes Fig. 9 A rear perspective view of the front assembly of FIG.
[0043] Fig.11 yes Fig. 9 A rear perspective view of the front assembly of FIG.
[0044] Fig.12 yes Fig. 9 A rear perspective view of the heater bag of the door assembly of the front assembly.
[0045] Fig.13 yes Fig. 9 A rear perspective view of the heater plate of the door assembly of the front assembly.
[0046] Fig.14 It is shown Fig.12 Heater bags and Figure 1 A perspective view of an installation of a fluid cartridge of a fluid regulating system.
[0047] Fig.15 yes Fig.14 Fluid Box and Fig.12 A perspective view of a heater bag.
[0048] Fig.16 Can be included in Figure 1 A fully exploded perspective view of one embodiment of a heater assembly within a fluid regulating system.
[0049] Fig.17 yes Fig.16 A partially exploded perspective view of a heater assembly.
[0050] Fig.18 An operation diagram is provided through which Figure 1 The fluid regulation system can cooperate with the dialysis system to form a fluid circuit for performing a fluid regulation cycle.
[0051] Fig.19 Shows Figure 1 Fluid regulation system and Fig.16An example setup of a dialysis system.
[0052] Fig. 20 Shown by Fig.16 The fluid circuit performs the fluid flow paths (indicated by the highlighted fluid lines) of the priming phase of the fluid regulation cycle.
[0053] Fig.21 Shown by Fig.16 The fluid circuit performs the fluid flow paths (represented by the highlighted fluid lines) of the infusion phase of the fluid regulation cycle.
[0054] Fig. 22 Shown by Fig.16 The fluid circuit performs the fluid flow paths (indicated by the highlighted fluid lines) of the treatment phase of the fluid regulation cycle.
[0055] Fig.23 Provided Figure 1 Block diagram of the control system of a fluid regulating system.
[0056] Fig.24 Provided Figure 1 Block diagram of the hardware system of the fluid regulation system.
[0057] Fig.25 Provided Figure 1 Block diagram of the software system of the fluid regulation system.
[0058] Fig.26 Shows Fig.18 Part of the operation diagram includes Figure 1 An ammonia detection system, sorbent cartridge and main reservoir for a fluid conditioning system.
[0059] Fig. 27 yes Fig.26 A cutaway perspective view of an ammonia sensor of an ammonia detection system.
[0060] Fig.28 yes Fig. 27 A cutaway perspective view of a baffle of an ammonia sensor.
[0061] Fig.29 yes Fig.26 A cross-sectional view of an ammonia detection system.
[0062] Fig.30 yes Fig.26 An overhead view of an ammonia detector of an ammonia detection system.
[0063] Fig.31 yes Fig.30 A perspective view of an ammonia detector.
[0064] Fig.32 yes Fig.30 Cross-sectional view of an ammonia detector.
[0065] Fig.33 It is shown that it is applicable to Fig.29 An example diagram of the reflectance spectroscopy operating principle of an ammonia detection system.
[0066] Fig.34 It shows that according to Fig.29 An example diagram of the reflectance spectroscopy operating principle of an ammonia detection system that can produce an analysis of percent reflectance ratios.
[0067] Fig.35 It is shown Fig.34 An example graph of the analysis of the moving average slope of the percent reflectivity ratio.
[0068] Fig.36 is a cutaway perspective view of the baffle of the ammonia sensor.
[0069] Fig.37 is a cutaway perspective view of the baffle of the ammonia sensor.
[0070] Fig.38 is a cutaway perspective view of the baffle of the ammonia sensor.
[0071] Fig.39 is an exploded perspective view of an ammonia sensor that may be used with a cooperating ammonia detector. DETAILED DESCRIPTION
[0072] Figure 1-4 A fluid regulating system 100 is shown that can be operated to prepare conditioned dialysate for a dialysis system. For example, the fluid regulating system 100 can be fluidly connected to the dialysis system to deliver "fresh" (e.g., purified, conditioned) dialysate to the dialysis system, collect "spent" (e.g., contaminated, unconditioned) dialysate from the dialysis system, and regenerate (e.g., purify) and condition the spent dialysate in a continuous fluid flow loop to recover the spent dialysate. Example dialysis systems with which the fluid regulating system 100 can be fluidly connected include hemodialysis (HD) systems, peritoneal dialysis (PD) systems, hemofiltration (HF), hemodiafiltration (HDF), and other related systems.
[0073] The fluid regulating system 100 includes: a housing 101 that contains or supports the components of the fluid regulating system 100; a fluid box 102 that includes a plurality of fluid lines that define various fluid paths; two relatively high-capacity pumps 103 that can circulate fluid within the fluid lines of the fluid box 102; and two relatively low-capacity pumps 104 that can deliver (e.g., infuse) a regulating agent into the fluid circulating within the fluid lines of the fluid box 102. The fluid regulating system 100 has a compact footprint that facilitates lifting and transporting the fluid regulating system 100. For example, the fluid regulating system 100 typically has a length of about 30 cm to about 50 cm, a width of about 30 cm to about 50 cm, a height of about 30 cm to about 50 cm, and a weight of about 15 kg to about 20 kg.
[0074] The housing 101 includes left and right side panels 105, 106, a handle 107 positioned along the side panels 105, 106 for carrying the fluid regulating system 100, a door assembly 108 that can be opened and closed to insert a heater bag, a front panel 109 to which the door assembly 108 is secured, a rear panel 110 and a bottom panel 111 that further enclose the internal components, an upper panel 112 that supports the fluid cartridge 102 and the pumps 103, 104, and a cover 113 that protects the fluid cartridge 102 and the pumps 103, 104. Example materials from which the exterior panels of the housing 101 may be made include plastics such as acrylonitrile butadiene styrene (ABS) and polycarbonate blends, among others.
[0075] The cover 113 is typically made of ABS or polycarbonate and is transparent or translucent to allow visual observation of the fluid cartridge 102 and pumps 103, 104. The cover 113 can be pivoted at a rear hinge 114 provided along the upper panel 112 to open or close the cover 113. The upper panel 112 carries two latches 115 that can be closed on the front edge 116 of the cover 113 to secure the cover 113 in the closed position. The latches 115 can also be pulled up and separated from the cover 113 to release the cover 113 from the closed position to access the fluid cartridge 102 and pumps 103, 104.
[0076] refer to Figure 5 , the fluid regulating system 100 also includes left and right internal support frames 117, 118 to which the left, right, front, rear, bottom and upper plates 105, 106, 109, 110, 111, 112 are attached. The internal support frames 117, 118 are typically formed from sheet metal.
[0077] Each pump 103, 104 is a peristaltic pump that includes a plurality of rollers positioned around the circumference of a rotatable frame (e.g., a motor) that carries fluid lines extending from the fluid cartridge 102. As the rotatable frame rotates, the rolling members apply pressure to the fluid lines, thereby forcing fluid to flow through the fluid lines.
[0078] Figure 6-8 1 and 2. Certain internal components of the fluid regulating system 100 are shown. For example, the fluid regulating system 100 also includes a plurality of pressure transducers 119, two temperature sensors 120, and an ammonia detector 121, each located in holes 122, 123, and 124 in the upper panel 112 for engaging with the fluid box 102. The pressure transducer 119 is implemented to contact the fluid box 102 (see Fig.15 ) is used to detect fluid pressure within certain fluid paths of the fluid cassette 102. The temperature sensor 120 is an infrared (IR) sensor that detects the temperature of the dialysate flowing through certain points of the fluid paths of the fluid cassette 102. The ammonia detector 121 is a red-green-blue (RGB) color sensor that can detect color changes on a paper strip within the fluid cassette 102 to determine the concentration of ammonium (e.g., which produces ammonia) in the dialysate flowing through a certain fluid path of the fluid cassette 102. The fluid regulation system 100 also includes circuitry for acquiring and regulating signals generated by a conductivity sensor provided on the fluid cassette 102, which will be discussed in more detail below.
[0079] The fluid regulating system 100 also includes a plurality of actuators 125 aligned with holes 126 in the upper panel 112 for individually and selectively moving a plurality of valves of the fluid cartridge 102. Each actuator 125 is mounted to a platform 127 of an internal frame 128 of the fluid regulating system 100 and includes a motor 129 and a drive unit 130 that can be moved (e.g., rotated or otherwise manipulated) by the motor 129. The drive unit 130 is provided with a coupling member 131 formed to engage a corresponding valve of the fluid cartridge 102 such that movement of the drive unit 130 causes movement of the valve. The internal frame 128 also includes a columnar support member 132 that supports and positions the upper panel 112 of the housing 101. The upper panel 112 also defines holes 133 that are positioned and sized to receive locating pins 134 for properly positioning the fluid cartridge 102 relative to the upper panel 112. With the fluid cartridge 102 in place, the locating pins 134 can be snapped down onto the upper panel 112 to lock the position of the fluid cartridge 102. The fluid regulating system 100 also includes a circuit board 135 that is equipped with electronics for operating the various electromechanical components of the fluid regulating system 100. For example, the electronics perform various stages for performing a fluid regulating cycle (as described below with reference to Figure 18-20104, controls valves for the fluid cassette 102, processes sensor signals, operates the actuator 125, operates the heater assembly 151, and runs control loops (e.g., control loops for regulating dialysate temperature, regulating pump speed to achieve a desired flow rate, regulating pump speed to achieve a desired dialysate chemistry, and ensuring device safety).
[0080] Reference again Figure 5 The fluid regulating system 100 also includes a support bracket 136 and a fan 137 carried in the support bracket 136 for cooling the circuit board 135 and other internal components of the fluid regulating system 100. The fluid regulating system 100 also includes a power source 138 and a support bracket 139 carrying an A / C input port 140.
[0081] Figure 9-13 Various views of the front assembly 141 of the fluid regulating system 100 are shown. The front assembly 141 includes the door assembly 108 and the front panel 109 of the housing 101. The door assembly 108 is pivotable relative to the front panel 109 at hinges 142 to allow the heater bag 153 to be loaded into the fluid regulating system 100. The hinges 142 are friction hinges disposed along opposite sides of the door assembly 108, such as Fig.12 shown.
[0082] The front panel 109 carries a latch assembly 143, which is connected to the upper panel 112 ( Figure 1-4 108 to the front panel 109 in the closed position. For example, depression of the button 144 adjusts the latch assembly 143 so that the door assembly 108 can be unlocked and pivoted from the closed position to the open position. Alternatively, the door assembly 108 can be pivoted inwardly from the open configuration until an oppositely positioned screw 145 (e.g., Fig.12 The shoulder screw shown in FIG. 1 engages the latch assembly 131 to lock the door assembly 108 in the closed position. The latch assembly 131 has a contact switch for determining whether the door assembly 108 is open or closed. Fig.11 and 13 , door assembly 108 includes an optical switch 147 that indicates whether a heater bag is inserted. In some embodiments, fluid regulating system 100 may not be operable when door assembly 108 is open.
[0083] Special References Fig. 9, the door assembly 108 supports a display screen 148 (e.g., a touch screen display) on which a graphical user interface (GUI) can be displayed and two control panels 149 that can be each equipped with a selector 150 (e.g., a button) for providing input at the GUI to operate the fluid regulation system 100. Example parameters and processes that can be controlled by a user via the display screen 148 using the selectors 150 include starting and stopping treatment, initiating a drain cycle, changing flow rates, initiating the priming phase of a fluid regulation cycle, initiating system preparation to begin a fluid regulation cycle, adjusting temperature based on patient comfort, confirming proper placement of the fluid cassette 102, or confirming proper placement of fluid lines interfaced with the pumps 103, 104.
[0084] refer to Figure 10-13 , the front assembly 141 includes components of a heater assembly 151 designed to regulate the fluid temperature of the dialysate transported along the fluid path of the fluid cassette 102. With particular reference to Fig.12 , the heater assembly 151 includes a heater bag 153 equipped with an input connection structure 154 and an output connection structure 155, which can interface with the fluid box 102 to allow the dialysate to be warmed by circulating through the heater bag 153. The heater bag 153 is formed as a plastic channel that has a generally flat collapsed shape when empty, expands when filled with fluid, and transfers heat from the external surface to the dialysate flowing through the heater bag 153.
[0085] Special References Fig.13 The heater assembly 151 also includes two plates 156 (eg, aluminum plates) that position and support the heater bag 153 and are heated to transfer heat to the fluid within the heater bag 153. Fig.14 When the door assembly 108 is in the open configuration, the heater bag 153 can be slid onto the two heater plates 156 within the door assembly 108 (in Fig.14 Special reference Figure 10-12 The heater assembly 151 also includes one or more heating elements (e.g., resistive heating elements not shown) by which the fluid in the heater bag 153 can be warmed, and the heater assembly 151 also includes two insulating pads 158 disposed on opposite sides of the heater bag 153. The one or more heating elements are carried by one or both of the two boards or otherwise attached to one or both of the two boards. The heater assembly 151 also includes a circuit board 159 that provides electronics for operating the heater assembly 151, a feed line 160 for each heating pad 156 for providing power, and a thermocouple connection structure 162 for determining the temperature of the corresponding heating plate 156.
[0086] Fig.15 and 16 Another embodiment of a heater assembly 170 that may be included in the fluid regulating system 100 instead of the heater assembly 151 is shown. The heater assembly 170 is similar in construction and function to the heater assembly 151 and thus includes a heater bag 153 sandwiched between two heater plates 156. The heater assembly 170 also includes two handles 171 attached to the heater bag 153 to facilitate placement of the heater bag 153; a u-shaped heater frame 172 that supports the heater bag 153; and two support members 173 that support the generally matrix structure of the heater plates 156. The support members 173 also serve to isolate the heater bag 153 and the heater plates 156 from surrounding components via an air gap 174 that is provided between the heater plates 156 and such components and defined by the matrix structure.
[0087] refer to Fig.17 The fluid box 102 is a single-use disposable cassette that includes a housing 200, a plurality of fluid lines 201 disposed within the housing 200, a plurality of valves 202 positioned along the fluid lines 201, two conductivity sensors 203 positioned along the fluid lines 201, an ammonia sensor 165 positioned along the fluid lines 201 for cooperating with the ammonia detector 121, two fluid line connectors (e.g., pump segment clamps) 204, and two fluid line connectors (e.g., pump segment clamps) 205. The fluid lines 201 cooperate with the heater bag 153 and the dialysis system to form a fluid circuit 350 for performing a fluid regulation cycle. For example, the fluid lines 201 include ports to which the input and output connection structures 154, 155 of the heater bag 153 can be connected to provide fluid communication between the fluid lines 201 and the heater bag 153. Fluid line connector 204 positions fluid line segment 206 around high capacity pump 103, while fluid line connector 205 positions fluid line segment 207 around low capacity pump 104. Fig.19 As shown, the fluid box 102 also includes additional fluid lines extending from the fluid box 102 to various fluid containers.
[0088] The valve 202 is a three-way valve by which two alternative fluid paths can be selected by the control system of the fluid regulating system 100. The lower portion of the valve 202 is formed to engage with the coupling member 131 of the actuator 125 for movement of the valve 202. Example types of valves 202 that can be included in the fluid cartridge 102 include rotary valves, push-pull valves, slide valves, and shuttle valves.
[0089] Fig.18 An operational diagram 300 is shown by which the fluid regulation system 100 may cooperate with a dialyzer 337 of a dialysis system 301 to form a fluid circuit 350 (represented by a solid line) for performing a fluid regulation cycle, while Fig.19 An example arrangement of a fluid regulating system 100 with a dialysis system 301 is shown. Example types of dialysis systems 301 that may be coupled to the fluid regulating system 100 include HD systems, PD systems, HF systems, and HDF systems. The fluid circuit 350 contains components of the fluid cassette 102 and various other components of the fluid regulating system 100.
[0090] For example, in addition to the above combination Figure 1-17 In addition to the components discussed, the fluid regulating system 100 also includes a control system 161 (eg, including circuit boards 135 , 159 and additional circuit boards for sensor circuits) for controlling various operations of the fluid regulating system 100 and various other peripheral components positioned along the fluid circuit 350 . These components include a perfusion tank 302 for collecting water to produce a dialysate (e.g., sometimes referred to as a dialysis fluid), a sorbent cartridge 303 for filtering tap water to provide purified water suitable for producing a dialysate and for purifying the dialysate exiting the dialysis system 301, a primary reservoir 304 for collecting fluid (e.g., unconditioned water or dialysate) exiting the sorbent cartridge 303, a secondary reservoir 305 for collecting fluid exceeding the capacity of the primary reservoir 304, a bag 306 for holding an electrolyte solution, a bag 307 for holding a salt-dextrose (SD) solution, a bag 308 for holding a dilution water (DW), and a bag 309 for holding a bicarbonate (BC) solution, which are positioned along the fluid flow path device 300.
[0091] The bags 306, 307, 309 are pre-filled with appropriate amounts of dry chemicals that can be dissolved in water to produce electrolyte solutions, saline-glucose solutions, and bicarbonate solutions. Each bag 306, 307, 309 includes a nozzle designed to increase the velocity of the fluid flow entering the bag 306, 307, 309 and to create the turbulence required to fully mix and dissolve the dry chemicals in the water.
[0092] Table 1 lists the approximate capacities of the various fluid-containing components of the fluid regulating system 100 .
[0093] part Capacity(mL) Filling tank(302) 8,000 Main storage (304) 7,500 Secondary storage (305) 4,500 Electrolyte Bags(306) 500 Salt / Glucose Bags(307) 160 Dilution water bag(308) 4,000 Bicarbonate Bags(309) 1,000
[0094] Table 1: Capacities of Fluid-Containing Components of Fluid Regulating System 100
[0095] The three-way valves 202 of the fluid box 102 are labeled V1-V7 in the fluid circuit 350. Each valve includes three fluid ports (a), (b), (c), through which the flow path in the valve can be adjusted. When two or three of the ports of the valve are closed, the valve can be referred to as closed, and when two or three of the ports of the valve are opened, the valve can be referred to as open. These valves include a perfusion valve V1, a dissolution valve V2, a bypass outflow valve V3, a bypass inflow valve V4, a BC / DW valve V5, a S / D / electrolyte valve V6, and a fluid selector valve V7. The fluid lines 201 of the fluid box 102 will be further cited separately below in conjunction with the operation of the fluid regulation system 100. The high-capacity pump 103 and the low-capacity pump 104 of the fluid regulation system 100 are labeled P1, P2 and P3, P4, respectively, in the fluid circuit 350. These pumps include cassette inflow pump P1 , dialysate pump P2, conductivity control pump P3, and electrolyte / salt-glucose pump P4. Table 2 lists the approximate operating ranges (eg, fluid flow rates) of pumps P1-P4.
[0096]
[0097]
[0098] Table 2: Operating Ranges of the Pumps of the Fluid Regulating System 100
[0099] The heater assembly 151 and the ammonia sensor 165 of the fluid regulation system 100 are labeled as heat exchanger HX and ammonia sensor NH, respectively, in the fluid circuit 350. The conductivity sensor 203 of the fluid box 102 is labeled as conductivity sensor CT1 associated with the fluid temperature upstream of the heat exchanger HX and conductivity sensor CT2 associated with the fluid temperature downstream of the heat exchanger HX. In addition to having the ability to measure fluid conductivity, the conductivity sensors CT1 and CT2 also have the ability to measure fluid temperature. Given that conductivity varies with temperature, in some embodiments, the temperature measured by the conductivity sensors CT1 and CT2 can be used to correct the conductivity values measured by the conductivity sensors CT1 and CT2 to provide temperature compensated conductivity measurements. In some embodiments, the fluid temperature measured by the conductivity sensor CT2 can also provide a safety check on the final temperature of the dialysate leaving the fluid regulation system 100 to flow into the dialysis system 303. The temperature sensors 120 of the fluid regulating system 100 are labeled in the fluid circuit 350 as the cartridge inlet temperature sensor T1 and the heat exchanger temperature sensor T2. The pressure transducers 119 of the fluid regulating system 100 are labeled in the fluid circuit 350 as pressure transducers PT1, PT2, PT3, and PT4.
[0100] The fluid regulation system 100 can operate in multiple phases to cooperate with the dialysis system 301 (e.g., with the dialyzer 337) to perform a fluid regulation cycle in which a dialysis treatment is administered to a patient via the dialysis system 301. For example, a fluid regulation cycle includes a priming phase, an infusion phase, and a treatment phase. A fluid regulation cycle typically has a total duration of about 135 minutes to about 300 minutes.
[0101] Fig. 20 1 shows the operation of the fluid regulation system 100 during a priming phase, wherein an initial volume of water is drawn into the fluid circuit 350 for subsequent production of dialysate. At the beginning of the priming phase, the priming tank 302 is filled with water from a water source (e.g., a container 134 of water, such as Fig.19 The priming tank 302 is filled with water (e.g., tap water, bottled water, reverse osmosis water, distilled water, or drinking water) to about 7.6 L, pump P1 is activated, and heat exchanger HX is activated. Water is pumped from the priming tank 302 into the fluid line 310 by pump P1, pumped into the fluid line 311 through ports (a) and (c) of valve V1, passes through temperature sensor T1, and then enters pump P1. In this stage of operation, pump P1 pumps water at a flow rate in the range of about 200 mL / min to about 600 mL / min, and powers heat exchanger HX to maintain the fluid temperature at a set point in the range of about 15° C. to about 42° C.
[0102] If the temperature sensor T1 detects that the water temperature is above about 42° C., a message is displayed on the display screen 148 to inform the user that the water temperature is too hot, the valve V1 is closed, and the pump P1 is turned off to prevent additional water from entering the fluid circuit 350. If the temperature sensor T1 detects that the water temperature is less than or equal to about 42° C., ports (a) and (c) of the valve V1 remain open, and the pump P1 pumps water into the sorbent cartridge 303 through the fluid line 312, then into the fluid line 313, through the ammonia sensor NH, and then into the main reservoir 304. In this stage of operation, the sorbent cartridge 303 purifies the water circulating in the fluid circuit 350 so that the water meets or exceeds the drinking water quality standards established by the Environmental Protection Agency (EPA) and the hemodialysis water quality standards established by the Association for the Advancement of Medical Instrumentation (AAMI) standards.
[0103] Once the main reservoir 304 has collected about 100 mL to about 500 mL of water, pump P2 is activated and pumped by pump P2 into fluid line 314, then into e-fluid line 315, through conductivity sensor CT1, and through heat exchanger HX1, which heats the water in fluid line 315 to a set point temperature. Pump P2 is controlled to pump water at a flow rate approximately equal to the flow rate at which pump P1 pumps water. Water moves from fluid line 315 through ports (c) and (a) of valve V2 to fluid line 316, through ports (b) and (a) of valve V7 into fluid line 317, through ports (c) and (a) of valve V5 into fluid line 318, and further into bag 308 until bag 308 is filled with water (e.g., dilution water) to about 3.5 L to about 4.0 L.
[0104] Next, close ports (a) and (c) of valve V5, close port (a) of valve V7, open port (c) of valve V7, so that pump P2 pumps water into fluid line 319 through ports (c) and (a) of valve V6, then into fluid line 320, and then further pumps into bag 306 until bag 306 is full of water to produce an electrolyte solution. Close ports (a) and (c) of valve V6, close port (c) of valve V7, reopen port (a) of valve V7, and open ports (b) and (c) of valve V5. Then, pump P2 pumps water into fluid line 317 through ports (c) and (b) of valve V5, then into fluid line 321, and then further pumps into bag 309 until bag 309 is full of water to produce a bicarbonate solution.
[0105] At this point in the priming phase, the set point temperature of heat exchanger HX is increased to a range of about 31° C. to about 39° C. (e.g., where 39° C. is the maximum temperature that heat exchanger HX can reach), and the flow rate of pump P2 is reduced to a value in the range of about 100 mL / min to about 300 mL / min to increase the exposure time of the water within heat exchanger HX to achieve a higher set point temperature. Ports (b) and (c) of valve V5 are closed, port (a) of valve V7 is closed, port (c) of valve V7 is opened, and ports (b) and (c) of valve V6 are opened. Thus, pump P2 pumps water through ports (c) and (b) of valve V6 into fluid line 319, then into fluid line 322, and further into bag 307 until bag 307 is full to produce a saline-glucose solution. The higher set point temperature of heat exchanger HX promotes the dissolution of the saline-glucose substance by the water flowing into bag 309. At this point during the fluid regulation cycle, the priming phase is complete, the priming tank 302 has been substantially emptied, pumps P1, P2 are turned off, and the infusion phase begins. The priming phase typically lasts for a duration of about 10 minutes to about 30 minutes (eg, about 20 minutes).
[0106] Fig.21 Operation of the fluid regulation system 100 is shown during an infusion phase, in which bicarbonate, saline, and glucose are added to water in the fluid circuit 350 to produce a dialysate. In particular, bicarbonate, saline, and glucose are added to the water in a controlled manner (e.g., under flow rate control) until the saline and glucose reach physiologically acceptable concentrations and until the bicarbonate produces a physiologically acceptable fluid conductivity and fluid pH. During the infusion phase, the heat exchanger HX is powered to maintain the fluid temperature at a set point in the range of about 35° C. to about 39° C.
[0107] At the beginning of the infusion phase, valve V7 is closed, port (a) of valve V2 is closed, port (b) of valve V2 is opened, ports (a) and (b) of valves V3 and V4 are opened, port (b) of valve V1 is opened, port (a) of valve V1 is closed, ports (b) and (c) of valve V6 remain open, and ports (b) and (c) of valve V5 are opened. Pumps P1 and P2 are immediately activated to pump water at a flow rate of about 300 mL / min to about 600 mL / min in fluid circuit 350. At the same time, pumps P3 and P4 are activated. Pump P3 pumps bicarbonate solution out of bag 309 at a flow rate of about 10 mL / min to about 100 mL / min, pumps it into fluid line 317, through pump P3, and then pumps it into fluid line 314. Pump P4 pumps the salt-glucose solution out of bag 307 at a variable flow rate, pumps it into fluid line 319, passes through pump P4, and then pumps it into fluid line 314. The flow rate of the initial pumping fluid of P4 is in the range of about 1 mL / min to about 100 mL / min. The flow rate gradually decreases at a rate of 1 / 2 decrease in periodic time increments of about 1 min. The flow rates of pumps P3 and P4 are set to completely add the infusion volume of BC solution and SD solution respectively on a single turn around fluid loop 350. Therefore, the flow rates of pumps P3 and P4 are related to the flow rates of pumps P1 and P2 during the infusion phase. For example, if the flow rates of pumps P1 and P2 are set to 200 mL / min, the flow rates of pumps P3 and P4 will be relatively slow. On the contrary, if the flow rates of pumps P1 and P2 are set to 600 mL / min, the flow rates of pumps P3 and P4 will be relatively fast.
[0108] Once bag 307 is emptied of the saline-glucose solution, port (b) of valve V6 is closed and port (a) of valve V6 is opened to allow pump P4 to pump electrolyte solution from bag 306 into fluid line 314 at a flow rate of about 0.5 mL / min to about 5 mL / min. Once the electrolyte solution reaches valve V3, the infusion phase is over and the treatment phase can begin. However, if the treatment phase does not begin immediately, the fluid regulation system 100 can be operated to continue circulating the dialysate around the fluid circuit 350 through fluid lines 311, 312, 313, 314, 315, 323, 336, 326, or allow the dialysate to remain static (e.g., not circulated) until the treatment phase begins. The infusion phase typically lasts for a duration of about 5 minutes to about 6 minutes.
[0109] Fig. 22 Operation of the fluid regulation system 100 is shown during a treatment phase in which bicarbonate, salt, and glucose are added to water in the fluid circuit 350 to produce a dialysate. The treatment phase includes a first phase in which bicarbonate solution is used to adjust the conductivity of the dialysate and a second phase in which dilution water is used to adjust the conductivity of the dialysate. Pumps P1, P2 pump the dialysate at a flow rate in the range of about 200 mL / min to about 600 mL / min. The set point temperature of the heat exchanger HX is maintained at a physiologically acceptable temperature within an acceptable range of about 35°C to about 39°C (e.g., about 37°C), which can be specifically selected by the user of the fluid regulation system 100 to make the patient feel comfortable. At any time during the treatment phase, if the dialysate fluid temperature measured at CT2 is outside the range of about 35°C to about 42°C, the fluid regulation system 100 will enter a bypass mode in which the dialysate will flow through fluid line 336 to bypass the dialysis system 301 via fluid lines 324, 325. When the fluid regulating system 100 is operating in the bypass mode, a message indicating that the fluid temperature is too low or too high will be displayed on the display screen 148. The fluid regulating system 100 will remain in the bypass mode until the fluid temperature stabilizes within an acceptable range.
[0110] During the first phase of the treatment phase, port (b) of valve V3 is closed, port (c) of valve V3 is opened to allow pump P2 to pump "fresh" dialysate (e.g., purified, conditioned dialysate) through fluid line 324 and into dialysis system 301, port (a) of valve V4 is closed, port (c) of valve V4 is opened to allow pump P1 to pump "used" dialysate (e.g., contaminated dialysate) out of dialysis system 301 through fluid line 325 and further into fluid line 326. Thus, bypass fluid line 336 extending between valves V3, V4 is closed. During the treatment phase, the used dialysate is infused with ultrafiltrate from the patient's blood within dialysis system 301. The ultrafiltrate carries with it toxic substances such as urea, all small water-soluble uremic toxins, and other toxic substances (e.g., guanidinosuccinic acid, methylguanidine, 1-methyladenosine, 1-methylinosine, N2, N2-dimethylguanosine, pseudouridine, arabinitol, mannitol, α-N-acetylarginine, orotidine, oxalate, guanidine, erythritol, creatine, orotic acid, phenylacetylglutamine, creatinine, inositol, γ-guanidinobutyric acid, β-guanidinopropionic acid, symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA), sorbitol, uridine, and xanthine).
[0111] The spent dialysate is pumped from fluid line 326 through ports (b) and (c) of valve V1, fluid line 311, pump P1, fluid line 312, and into sorbent cartridge 303. Within sorbent cartridge 303, toxic substances are removed (e.g., filtered out) from the spent dialysate to produce a "regenerated" dialysate (e.g., purified, but unconditioned dialysate) that flows out of sorbent cartridge 303 and into fluid line 313, through ammonia sensor NH, and into primary reservoir 304. In some cases, the volume of regenerated dialysate within primary reservoir 304 exceeds the capacity of primary reservoir 304 and thus flows through fluid line 327 to secondary reservoir 305, which remains in fluid communication with primary reservoir 304 throughout the treatment phase. Pump P2 pumps the regenerated dialysate out of primary reservoir 304, into fluid line 314, and into pump P2. Although the regenerated dialysate exiting the sorbent cartridge 303 removes toxic substances absorbed from the patient's blood in the dialysis system 301, the regenerated dialysate must be further conditioned to meet acceptable physiological properties before being circulated back into the dialyzer 337 of the dialysis system 301 as fresh dialysate.
[0112] Thus, pump P4 continues to pump electrolyte solution from bag 306 at a flow rate related to (e.g., a fraction of) the flow rate at which pump P2 pumps dialysate, and pumps it into fluid line 320, through ports (a) and (c) of valve V6, into the upper section of fluid line 319, through pump P4, and into fluid line 314. Thus, pumps P2 and P4 together form a closed-loop pump control circuit 332 that controls the flow rate at which pump P4 pumps electrolyte solution, which is in the range of about 0.5 mL / min to about 5 mL / min. In addition, pump P3 continues to either pump bicarbonate solution from bag 309 or dilution water from bag 308, through port (c) of valve V5, into the upper section of fluid line 317, through pump P3, and into fluid line 314 to further condition the dialysate.
[0113] As the dialysate passes through pump P2 and conductivity sensor CT1, conductivity sensor CT1 detects the conductivity of the dialysate. Based on the continuous measurement of the conductivity of the dialysate, either bicarbonate solution or dilution water is continuously selected to be added to the dialysate through port (c) of valve V5, and the flow rate of the dialysate pumped by pump P3 is continuously adjusted to maintain the conductivity of the dialysate within a physiologically acceptable range of 13.5 mS / cm to 14.2 mS / cm. Typically, as the difference between the measured conductivity and the acceptable conductivity increases, the flow rate of the fluid pumped by pump P3 increases. Therefore, as the difference between the measured conductivity and the acceptable conductivity decreases, the flow rate of the fluid pumped by pump P3 decreases. In this way, the conductivity meter CT1 and pump P3 together form a closed-loop pump control loop 331 that regulates the flow rate of the fluid pumped by pump P3. If the conductivity of the dialysate is too low during the first phase of the treatment phase, bicarbonate solution is infused into the dialysate to increase the conductivity.
[0114] After passing through the conductivity sensor CT1, the dialysate flows through the heat exchanger HX and the temperature sensor T2. Based on the fluid temperature detected by the temperature sensor T2, the power level of the heat exchanger HX is adjusted to maintain the temperature of the dialysate at the set point temperature of the heat exchanger HX. In this way, the temperature sensor T2 and the heat exchanger HX form a closed-loop heater control circuit 333. The dialysate flows from the fluid line 315 into the fluid line 323 through the ports (c) and (b) of the valve V2 and passes through the conductivity sensor CT2. When the dialysate passes through the conductivity sensor CT2, the conductivity sensor CT2 performs a second check (e.g., downstream of the heat exchanger HX) to detect the conductivity of the dialysate.
[0115] If the conductivity of the dialysate is outside the acceptable range (e.g., too low or too high) but within a predetermined range (e.g., a range wider than the acceptable range), the safety system in electrical communication with the conductivity sensor will adjust the infusion flow rate of the bicarbonate solution or dilution water to achieve a conductivity within the acceptable range. If the conductivity level of the dialysate is outside the predetermined physiological safety range, in some embodiments, the fluid regulation system 100 will attempt to restore safe fluid parameters and continue treatment. For example, valves V3 and V4 will adjust to direct fluid through the bypass fluid line 336 and close the fluid lines 324, 325 until the conductivity stably reaches the physiological safety range again, at which time valves V3, V4 will adjust to close the bypass fluid line 336 and direct fluid to and from the dialysis system 301 via the fluid lines 324, 325. In some embodiments, the user may also be instructed to check that the fluid levels of the bicarbonate solution and dilution water are non-zero when restoring the conductivity to a physiologically safe range.
[0116] Over time, the sorbent cartridge 303 changes the composition of the regenerated dialysate leaving the sorbent cartridge 303 during the first phase of the treatment phase (e.g., during the early initial phase when the patient's blood is initially circulated through the dialysis machine 301). For example, during the first phase of the treatment phase, the level of toxic substances in the spent dialysate is relatively high. The sorbent cartridge 303 converts urea into ammonium and captures the ammonium within one or more filter layers within the sorbent cartridge 303 to remove ammonium from the dialysate. While the filter layers capture ammonium, the filter layers release sodium cations and other cations into the dialysate via cation exchange, which increases the conductivity and / or lowers the pH of the regenerated dialysate leaving the sorbent cartridge 303.
[0117] During the first phase of the treatment phase, the spent dialysate entering the sorbent cartridge 303 contains less toxic substances (e.g., removed from the patient's blood as uremic toxins), and the sorbent cartridge 303 releases more sodium ions. As a result, the conductivity of the dialysate leaving the sorbent cartridge 303 gradually increases over time. Once the conductivity of the dialysate reaches a predetermined value in the range of about 13.8 mS / cm to about 14.0 mS / cm, the first phase of the treatment phase of using bicarbonate to adjust the conductivity of the dialysate ends, and the second phase of the treatment phase begins.
[0118] In the second phase of the treatment phase (e.g., the final phase later), bicarbonate is no longer used to adjust (e.g., increase) the conductivity of the dialysate, and dilution water is the only substance used at valve V5 to adjust (e.g., reduce) the conductivity of the dialysate until the end of the treatment phase (e.g., the end of the second phase). Therefore, port (b) of valve V5 is closed, and port (a) of valve V5 is opened. If the conductivity of the dialysate is too high during the second phase of the treatment phase, dilution water is infused into the dialysate to reduce the conductivity of the dialysate.
[0119] During the second phase of the treatment phase, the amount of ammonium captured in the sorbent cartridge 303 increases, causing the ability of the sorbent cartridge 303 to absorb additional ammonium to gradually decrease, and once the sorbent's capacity to absorb ammonium is exhausted, the level of ammonia (e.g., generated by ammonium) in the regenerated dialysate eventually increases. An ammonia sensor NH detects the level of ammonia in the regenerated dialysate at a location downstream of the sorbent cartridge 303.
[0120] The treatment phase (e.g., including both the first phase and the second phase) typically lasts for a duration of about 120 min to about 300 min. For example, 240 min (e.g., 4 hours) is a standard duration that typically achieves adequate treatment for the vast majority of patients. In addition, most treatment phases will end after four hours without reaching the threshold ammonium concentration of 2 mg / dL (e.g., never approaching exhaustion of the filtration capacity of the sorbent cartridge 303). The fluid regulation system 100 will sound an audio alarm indicating that the treatment has been successfully completed and the patient can disconnect him or herself from the dialyzer 337. However, if the ammonium level in the dialysate (e.g., detected by the ammonia sensor NH) indicates that the sorbent cartridge 303 is no longer absorbing enough ammonium from the spent dialysate to maintain the ammonium level at or below an acceptable value of about 2 mg / dL before the standard treatment duration, then the treatment phase will end prematurely. This situation occasionally occurs for larger patients with very high blood urea nitrogen (BUN) levels.
[0121] Once the treatment phase is over, the spent dialysate in the fluid circuit 350 can be drained and disposed of as waste. In some examples, bags 306, 307, 308, 309 and various fluid lines can be manually removed and discarded while still containing dialysate. In some examples, the patient can disconnect from the dialysis system 301 and drain the fluid lines 323, 326 to the waste reservoir to drain the various components of the fluid regulation system 100. In some examples, the fluid regulation system 100 can be operated to run either or both of the pumps P1, P2 forward or reverse to drain any of the bags 306, 307, 308, 309, the sorbent cartridge 303, the perfusion tank 302, the primary reservoir 304, and the secondary reservoir 305. In some examples, the fluid regulation system 100 can be operated to run pumps P4 and P3 forward to drain bags 306, 307 and 308, 309. In some examples, such operation of pumps P4, P3 may be performed based on the reading of conductivity meter CT1. For example, upon detection of a sufficiently low threshold conductivity, it may be assumed that electrolyte bag 306 has been drained so that the next bag or fluid line may be drained.
[0122] Throughout the fluid regulation cycle, pressure transducers PT1, PT2, PT3, PT4 detect fluid pressure to adjust the pump flow rate. For example, during all stages of the fluid regulation cycle (e.g., perfusion, infusion, and treatment stages), pressure transducer PT1 forms a closed-loop pump control loop 328 with pump P1 by detecting the fluid pressure of the dialysate in fluid line 312 (e.g., downstream of pump P1) and providing a feedback signal indicating the fluid pressure to pump P1. Based on the fluid pressure of the dialysate, the angular velocity (e.g., RPM level) of pump P1 is adjusted to maintain the flow rate within a desired range. During the treatment stage of the fluid regulation cycle, pressure transducer PT4 forms an additional closed-loop pump control loop 329 with pump P1 by detecting the fluid pressure of the dialysate leaving the dialysis system 301 (e.g., upstream of pump P1) and providing a positive signal indicating the fluid pressure to pump P1. Based on the fluid pressure of the dialysate, the angular velocity of pump P1 is adjusted to closely match the flow rate at pump P1 with the flow rate of dialysate exiting the dialysis system 301. Thus, the fluid pressure of the dialysate within fluid line 312 (e.g., upstream of pump P1) is at least partially affected by the fluid pressure of the dialysate exiting the dialysis system 301 (e.g., upstream of pump P1).
[0123] Similarly, during all phases of the fluid regulation cycle (e.g., priming, infusion, and treatment phases), the pressure transducer PT2 forms a closed-loop pump control loop 330 with the pump P2 by detecting the fluid pressure of the dialysate in the fluid line 315 (e.g., downstream of the pump P2) and providing a feedback signal indicative of the fluid pressure to the pump P2. Based on the fluid pressure of the dialysate, the angular velocity of the pump P2 is adjusted to maintain the flow rate within a desired range. As described above, during the treatment phase of the fluid regulation cycle, the flow rate at which the pump P3 pumps the fluid is regulated by the feedback signal from the conductivity meter CT1 to form a pump control loop 331, while the flow rate at which the pump P4 pumps the electrolyte solution is regulated by the feedback signal from the pump P2 to form a pump control loop 332.
[0124] During all phases of the fluid regulation cycle, pressure transducers PT3 and PT4 monitor the operation of the dialyzer 337. If the measurements of pressure transducers PT3 and PT4 indicate that no fluid is flowing through the dialyzer 337, the fluid regulation system 100 will enter a bypass mode to allow dialysate to flow through fluid line 336 and avoid delivering dialysate to the dialysis system 301 via fluid lines 324, 325.
[0125] Fig.23 A block diagram of a control system 161 is provided. The control system 161 includes a processor 410, a memory 420, a storage device 430, and an input / output interface 440. In some embodiments, the control system 161 includes more than one processor 410, memory 420, storage device 430, and / or input / output interface 440. Each of the components 410, 420, 430, and 440 can be interconnected, for example, using a system bus 450. The processor 410 is capable of processing instructions for execution within the control system 161. The processor 410 can be a single-threaded processor, a multi-threaded processor, or a quantum computer. The processor 410 is capable of processing instructions stored in the memory 420 or the storage device 430.
[0126] The memory 420 stores information within the control system 161. In some embodiments, the memory 420 is a computer-readable medium. The memory 420 may be, for example, a volatile memory unit or a non-volatile memory unit. The storage device 430 is capable of providing mass storage for the control system 139. In some embodiments, the storage device 430 is a non-transitory computer-readable medium. The storage device 430 may include, for example, a hard disk device, an optical disk device, a solid-state drive, a flash drive, a magnetic tape, or some other mass storage device. Alternatively, the storage device 430 may be a cloud storage device, for example, a logical storage device including multiple physical storage devices distributed on a network and accessed using the network.
[0127] The input / output interface 440 provides input / output operations for the control system 161. In some embodiments, the input / output interface 440 includes one or more of a network interface device (e.g., an Ethernet card), a serial communication device (e.g., an RS-232 10 port), and / or a wireless interface device (e.g., an 802.11 card, a 3G wireless modem, or a 4G wireless modem). In some embodiments, the input / output device includes a driver device that is configured to receive input data and send output data to other input / output devices, such as a keyboard, a printer, and a display device (e.g., a display screen 148). In some embodiments, mobile computing devices, mobile communication devices, and other devices are used.
[0128] In some embodiments, the input / output interface 440 includes at least one analog-to-digital converter 441. The analog-to-digital converter converts analog signals into digital signals, e.g., digital signals suitable for processing by the processor 410. One or more sensing elements communicate with the analog-to-digital converter 441, as will be discussed in more detail below.
[0129] In some embodiments, control system 161 is a microcontroller. A microcontroller is a device that contains multiple components of a computer system in a single electronic package. For example, a single electronic package may contain processor 410, memory 420, storage device 430, and input / output interface 440.
[0130] Fig.24 and 25 A block diagram of the hardware system 500 and the software system 600 of the fluid regulating system 100 provided by the control system 161 is provided. Fig.24 As shown, the hardware system 500 is provided by a circuit board for generating a GUI for display on the display screen 148 and one or more circuit boards 135 for controlling the electromechanical peripheral components of the fluid regulating system 100 and various electromechanical peripheral components. The software system 600 can be decomposed into an external view 610, an application layer 620, and a driver layer 630. The external view 610 includes a user interface, lights, sounds, and a debug port provided by the GUI. The application layer 620 includes business logic, and the driver layer 630 is configured to enable implementation of peripheral device-specific code (e.g., communication protocols and stepper motor drivers).
[0131] Although already Figure 23-25 An example control system 161, an example hardware system 500, and an example software system 600 are described respectively, but the implementation of the above-described subject matter and functional operations may be implemented in other types of digital electronic circuits, or in computer software, firmware, or hardware, including the structures disclosed in this specification and their structural equivalents, or in a combination of one or more thereof.
[0132] In some embodiments, the ammonia sensor 165 and the cooperating ammonia detector 121 together provide an ammonia detection system 700 for the fluid conditioning system 100, such as Fig.26 As shown above. Fig.18 and 19 As discussed, the sorbent cartridge 303 is designed to regenerate spent dialysate that is circulated through the fluid circuit 350. Spent dialysate contains urea that has diffused from the patient's blood through the dialyzer 337, and ammonium is produced in the dialysate due to the decomposition of the urea within the sorbent cartridge 303. Therefore, the sorbent cartridge 303 is designed to remove ammonium as part of the spent dialysate regeneration process. Ammonium that is not removed from the dialysate within the sorbent cartridge 303 can generate ammonia within the circulating dialysate. Therefore, the ammonia detection system 700 is positioned downstream of the sorbent cartridge 303 (e.g., but within the sorbent cartridge 303). Fig.18 ) is used to determine whether the ammonium level in the regenerated dialysate leaving the sorbent cartridge 303 is within an acceptable range.
[0133] like Fig.26 As shown, the sorbent box 303 includes various layers that together regenerate the spent dialysate. For example, the sorbent box 303 includes a first carbon layer 701, a urease layer 702, an alumina layer 703, a second intermediate carbon layer 704, a zirconium phosphate (ZP) layer 705, and a hydrated zirconium oxide plus chloride counter ion (HZOCl) layer 706. The carbon layers 701, 704 adsorb heavy metals, chloramines, other contaminants that may be present in tap water, and many organic and middle molecular uremic solutes found in spent dialysate, such as creatinine and uric acid. The urease layer 702 decomposes urea in the dialysate into ammonium (e.g., positively charged ammonium ions, NH 4 + ) and bicarbonate. Alumina layer 703 immobilizes urease and other proteins leached from urease layer 702. ZP layer 705 adsorbs ammonium (e.g., thereby removing ammonium from circulating dialysate), and HZOCl layer 706 adsorbs phosphate leached from ZP layer 705 or from the patient via dialyzer 337.
[0134] The ZP layer 705 has a fixed ammonium adsorption capacity. Therefore, if the ammonium adsorption capacity of the ZP layer 705 is exceeded during the treatment phase of the fluid conditioning cycle of the regenerated dialysate, the ammonium within the sorbent box 303 may begin to leak into the outflowing dialysate. Ammonium itself may not pose a direct threat to the patient's health. However, ammonium transferred to the patient (e.g., into the patient's blood) through the dialyzer 337 can produce ammonia (e.g., ammonia gas) in the fluid circuit 350 or the patient's blood, and ammonia is toxic above a certain threshold concentration (e.g., approximately 100 μg / dL). Depending on the pH and temperature of the dialysate within the fluid circuit 350, trace amounts of ammonia gas are generated in the dialysate by the ammonium present in the dialysate. Therefore, the ammonia detection system 700 is positioned just downstream of the sorbent box 303 to identify ammonia leaks in the dialysate, thereby protecting the patient from excessive exposure to ammonia.
[0135] refer to Fig.26 and 27 , the ammonia sensor 165 includes a connector body 707, which is assembled with the fluid line 313 of the fluid circuit 350 in the disposable fluid cartridge 102. The ammonia sensor 165 also includes a sensor housing 709 positioned in the receiving portion 708 of the connector body 707, a gas permeable membrane 711 positioned in the sensor housing 709, a retaining ring 712 (e.g., an O-ring member) that positions and supports the membrane 711, a sensor 713 positioned adjacent to the membrane 711, a lens 714 (e.g., a borosilicate lens) that closes the opening of the sensor housing 709, and a baffle 715 positioned in the vertical flow channel 716 of the connector body 707.
[0136] The sensor housing 709 is an opaque component that absorbs ambient light so that most of the light radiated to the sensor 713 is provided by the ammonia detector 121, as will be discussed in more detail below. The sensor housing 709 has a generally cylindrical outer shape for being placed in the receiving portion 708 of the connector body 707, and typically has an outer diameter of about 1.11 cm to about 1.36 cm. The sensor housing 709 can be made of polycarbonate or one or more other materials. The membrane 711 is permeable to ammonia vapor so that the vapor can reach the sensor 713 through the membrane 711. The membrane 711 and the sensor 713 typically have a diameter of about 0.94 cm to about 1.08 cm (e.g., about 0.95 cm). The sensor 713 is provided as a paper (e.g., cellulose paper) layer sandwiched between the membrane 711 and the lens 714. In some embodiments, the paper layer is coated with bromocresol green at a concentration of about 500 ppm to about 1200 ppm (e.g., 1,000 ppm) and malonic acid at a concentration of about 500 ppm to about 1000 ppm (e.g., about 1,000 ppm). The inductor 713 typically has a thickness of about 0.15 mm to about 0.32 mm (e.g., about 0.24 mm).
[0137] Bromocresol green is an acid-base indicator. In the presence of an acidic substance (e.g., pH less than about 3.4), bromocresol green forms a complex having a yellow color, and in the presence of a relatively alkaline substance (e.g., pH greater than about 5.4), bromocresol green forms a complex having a blue color. Since the sensor 713 is initially immersed in an acid (e.g., malonic acid), the sensor 713 initially has a yellow color. Ammonia is alkaline and therefore changes the color of the sensor 713 from yellow to blue upon contact with the sensor 713. Detection of this color change at the sensor 713 can occur automatically at the cooperating ammonia detector 121, so that the dialysis treatment can be stopped to avoid exposing the patient to a toxic threshold concentration of ammonia.
[0138] refer to Fig. 27 and 28 , the baffle 715 is a small plate that provides an obstruction to the flow of the circulating dialysate. For example, the baffle 715 is oriented perpendicular to the volume flow direction 717 of the circulating dialysate in the vertical flow channel 716, which is located along the horizontal flow channel 710 of the connector body 707. The baffle 715 is designed to create a disturbance in the flow of the dialysate to promote any ammonia vapor in the dialysate to flow upward toward the membrane 711 along the sensing direction 718. The baffle 715 includes a relatively wide base 730 and a relatively narrow protrusion 732 extending from the base 730 into the opening of the sensor housing 709 to define a planar flow area 734 along the periphery of the protrusion 732 and the upper edge of the base 730.
[0139] The width of the base 730 is equal to the inner diameter of the vertical flow channel 716, so that the circulating dialysate is forced to flow upward through the base 730 and through the flow area 734. The flow area 734 is the cross-sectional area defined between the protrusion 732 and the adjacent inner surfaces of the sensor housing 709, the retaining ring 712, and the membrane 711. Such a flow path increases the velocity of the dialysate through the flow area 734 because the flow area 734 is smaller than the cross-sectional area of the horizontal flow channel 710. The increased velocity creates disturbances in the circulating dialysate and thus increases the rate at which ammonia vapor diffuses through the membrane 711 for early detection of ammonia in the dialysate, which is an indicator of ammonium leakage into the dialysate within the sorbent cartridge 303. The protrusion 732 reduces the distance between the flow path and the membrane 711, and the ammonia vapor diffuses through the interstitial space 736 (e.g., interstitial volume) formed between the protrusion 732 and the membrane 711.
[0140] The base 730 and vertical flow channels 716 of the baffle 715 typically have a diameter of about 0.5 cm to about 1.0 cm. The horizontal flow channels 710 typically have a diameter of about 0.5 cm to about 1.2 cm. The protrusion 732 of the baffle 715 typically has a width of about 0.5 cm to about 1.5 cm and a length of about 1.0 cm to about 1.8 cm. The baffle 715 typically has an overall height of about 1.8 cm to about 2.8 cm and a thickness of about 0.13 cm to about 0.2 cm. In some embodiments, the annular cross-sectional flow area 734 falls within about 70 mm. 2 Up to about 90mm 2 (For example, about 80mm 2 ). When the circulating dialysate flows through the flow area 734, the ammonia vapor in the dialysate diffuses to the sensor 713 through the membrane 711, causing the sensor 713 to change from yellow to blue. The light reflected from the sensor 713 is projected to the ammonia detector 121 through the lens 714.
[0141] refer to Figure 29-32 , the ammonia detector 121 is arranged along the upper panel 112 (eg, reference Figure 6 and 7The ammonia detector 121 is a durable, non-disposable component of the housing 101 of the fluid regulating system 100, aligned with and positioned below the ammonia sensor 165. The ammonia detector 121 operates according to the principle of reflectance spectroscopy to detect the color change of the sensor 713. The ammonia detector 121 includes: a housing 719 defining two grooved through-passages 723 at which the housing 719 can be secured to a support member; a printed circuit board (PCB) 727 attached to the housing 719, a light emitting diode (LED) 721 in a side opening 724 of the housing 719 that radiates light toward a lens 714 of the ammonia sensor 165; a detector 728 for receiving light reflected from the sensor 713; a digital detector circuit 720 (e.g., a digital RGB detector circuit) adjacent to the detector 728 for processing signals received at and transmitted from the detector 728; a lens 722 (e.g., a borosilicate lens) in the central opening 725 of the housing 719 that focuses the reflected light onto the detector 728; and a control system 161 (reference numeral 161) for placing the PCB 727 in contact with the fluid regulation system 100. Fig.23 )Connector 726 for electrical communication.
[0142] The housing 719 is an opaque component that absorbs ambient light so that the majority of the light radiated toward the ammonia sensor 165 is provided by the LED 721. The LED 721 emits white broadband light toward the ammonia sensor 165, where it passes through the lens 714 and illuminates the sensor 713. The broadband light emitted by the LED 721 typically has a wavelength in the range of about 450 nm to about 750 nm. The lens 722 narrows the field of view of the sensor 713 to a narrow central area of the sensor 713 to further reduce the effects of any ambient light that may be reflected by the sensor 713.
[0143] Detector 728 is a multi-color bandpass component (e.g., a red-green-blue detector) that includes multiple channels for detecting visible light of different colors reflected from sensor 713. For example, detector 728 includes a red channel 731 that detects visible red light with a wavelength in the range of about 630 nm to about 700 nm, a green channel 733 that detects green light with a wavelength in the range of about 530 nm to about 575 nm, a blue channel 735 that detects blue light with a wavelength in the range of about 450 nm to about 490 nm, and a broadband channel 737 that detects white light with a wavelength in the range of about 450 nm to about 750 nm. By adjusting LED 721 to a nominal value in the middle range of broadband channel 737, a standardized reference point is established for the red, green, and blue channels 731, 733, 735. Once LED 721 is set to this value at the beginning of treatment, the system monitors the red, blue, and green channels 731, 733, and 735 to observe the rate change from yellow to blue associated with the detection of ammonia in the dialysate for sensor 713, which is an indicator of ammonium leakage from the sorbent box 303 into the dialysate.
[0144] Due to the light radiated by the LED 721 toward the ammonia sensor 165 , the ammonia sensor 165 reflects the light at a specific wavelength based on the color of the ammonia sensor 165 . Fig.33 This behavior of reflected light according to the principles of reflectance spectroscopy is illustrated in the example graph 738. Yellow light has a wavelength in the range of about 570 nm to about 640 nm, which is a mixture of visible red light and green light. Thus, when the ammonia sensor 165 is yellow, the ammonia sensor 165 reflects light in the red and green channels of the detector 728, with the highest color intensity corresponding to the visible red wavelength of about 612 nm. Blue absorbs visible red light while reflecting blue light. Thus, as the ammonia sensor 165 changes from yellow to blue, the intensity of the visible red light decreases, while the intensity of the blue light reflected from the ammonia sensor 165 increases, with the highest color intensity corresponding to the blue wavelength of about 442 nm.
[0145] A change in the ratio of the color intensity of the blue light reflected from the sensor 713 to the color intensity of the visible red light reflected from the sensor 713 (e.g., a ratiometric color intensity change) can be used to detect a certain increase in the concentration of ammonia in the dialysate, which corresponds to a certain degree of ammonium leakage into the dialysate as the dialysate circulates through the sorbent cartridge 303. Fig.33 , the fraction of incident electromagnetic power at sensor 713 (e.g., associated with white light radiated from LED 721) that is subsequently reflected by sensor 713 is defined as reflectance (e.g., % reflectance), which can vary as a function of the wavelength of the reflected light.
[0146] Fig.34An example graph 740 is provided of the ratio of blue reflectance to red reflectance (e.g., reflectance ratio) from the sensor 713 as a function of time during an ammonium infusion process performed at a benchtop setup including the ammonia detection system 700 and the sorbent cartridge 303. Such analysis may be performed at one or both of the digital detector circuit 720 of the ammonia detector 121 and the circuitry of one or more processors implementing the control system, such as the processor 410 of the control system 161. The benchtop setup otherwise mimics the fluid flow parameters of the fluid regulation system 100. The reflectance ratio is shown as multiplied by 100 (e.g., percent reflectance ratio) and is labeled %B / R in the graph 740. Thus, a percent reflectance ratio of less than 100 is measured when the intensity of blue light reflected from the sensor 713 is less than the intensity of red light reflected from the sensor 713, which corresponds to an ammonium concentration in the circulating dialysate below a certain breakthrough concentration (e.g., approximately 2 mg / dL) and to a yellow color of the sensor 713.
[0147] In contrast, a percent reflectance ratio greater than 100 is measured when the intensity of blue light reflected from sensor 713 is greater than the intensity of red light reflected from sensor 713, which corresponds to an ammonium concentration in the circulating dialysate above the breakthrough concentration and to a blue color of sensor 713. In some embodiments, a breakthrough concentration of approximately 2 mg / dL defines a point at which the sorbent cartridge 303 is depleted of capacity. In some embodiments, the breakthrough concentration is a multiple of the allowable ammonium concentration in the dialysate that may be caused by channel transport or other mass transfer inefficiencies. For example, a breakthrough concentration of approximately 2 mg / dL may be equal to approximately four times the allowable ammonium concentration of approximately 0.5 mg / dL in the circulating dialysate. In some examples, the ammonium concentration in the circulating dialysate may be four times or more the ammonium concentration in the patient's blood, because the patient's total blood volume is typically at least four times the volume of dialysate circulating in the fluid circuit 350. For example, a breakthrough ammonium concentration of approximately 2 mg / dL in the circulating dialysate may correspond to an ammonium concentration of approximately 0.5 mg / dL in the patient's blood. An ammonium concentration of approximately 0.5 mg / dL in the patient's blood, which may correspond to an ammonia concentration of approximately 7 μg / dL to approximately 10 μg / dL in the patient's blood (e.g., depending on the patient's weight), is well below the toxic ammonia threshold concentration of approximately 100 μg / dL.
[0148] In example graph 740, a moving average technique is applied to the reflectance ratio data (e.g., with a moving time window of 5 minutes and a sampling rate of 0.42 seconds) to smooth the curve of the percent reflectance ratio (e.g., to minimize the effects due to noise factors). Thus, the first data point on the curve of the percent reflectance ratio does not appear until five minutes after the ammonium infusion process begins.
[0149] The ammonium infusion process includes respective first, second, third, and fourth phases 741, 742, 743, 744. In the first phase 741, the circulating dialysate is maintained at a room temperature of about 15°C to about 37°C. In some examples, the first phase 741 corresponds to a priming phase performed by the fluid regulation system 100, in which an initial volume of water is drawn into the fluid circuit 350 for subsequent production of the dialysate, as described above with reference to Fig. 20 In the second phase 742, the circulating dialysate is warmed to a physiological temperature (e.g., approximately 37° C.). In some examples, the second phase 742 corresponds to an infusion phase performed by the fluid regulation system 100, in which bicarbonate, saline, and glucose are added to the water in the fluid circuit 350 to produce the dialysate, as described above with reference to Fig.21 discussed.
[0150] In the third phase 743, ammonium is initially infused into the circulating dialysate and begins to accumulate exponentially in the dialysate until an ammonium breakthrough concentration is reached. In some examples, the third phase 743 can correspond to the first phase of a treatment phase performed by the fluid regulation system 100, in which the conductivity of the dialysate is adjusted using a bicarbonate solution, as described above with respect to Fig. 22 In the fourth stage 744, ammonium continues to be infused into the circulating dialysate and accumulates exponentially in the circulating dialysate to exceed the breakthrough concentration. In some examples, the fourth stage 744 corresponds to the second stage of the treatment phase performed by the fluid regulation system 100, in which the conductivity of the dialysate is adjusted using dilution water, as described above with reference to Fig. 22 discussed.
[0151] Since the sensor 713 is initially yellow (e.g., not exposed to ammonia) at the beginning of the first stage 741, the percent reflectivity ratio is initially less than 100 because the sensor 713 reflects visible light with a greater red intensity than a blue intensity. Due to temperature-associated changes in the reflectance spectrum, the percent reflectivity ratio rises during the second stage 742 of the ammonium infusion process (e.g., despite continued limited exposure to ammonia). After the ammonium is infused during the third stage 743, the percent reflectivity ratio rises to 100 (e.g., corresponding to the ammonium breakthrough concentration) because the sensor 713 is exposed to increasing concentrations of ammonia (e.g., generated by ammonium in the dialysate) and therefore reflects light with increasing blue intensity.
[0152] Analyzing the reflectivity at sensor 713 as a ratio of blue and red intensities amplifies the detection of ammonia within the circulating dialysate, as compared to analyzing the reflectivity at the sensor as separate, individual absolute values of blue and red intensities according to conventional reflectivity spectroscopy techniques for ammonia detection. For example, both the numerator and denominator of the reflectivity can be changed (e.g., such that the value of the reflectivity ratio varies significantly), whereas conventional techniques only consider the absolute value of the blue intensity or the absolute value of the red intensity of light reflected from the ammonia sensor. Examining the reflectivity as a ratio also avoids false alarm conditions that may be observed during the period when the dialysate is heated to physiological temperature due to temperature-related changes in the reflectivity spectrum using conventional techniques, as will be described below with reference to Fig.34 discussed in more detail.
[0153] In some embodiments, the sensor 713 may include natural variations caused by one or more of the assembly process, paper smoothness, and solution uniformity (e.g., uniformity in the coating of bromocresol green and malonic acid). For example, paper smoothness may change the reflectance values of blue and red, which may cause a false alarm to occur. In other cases, solution non-uniformity on the sensor paper may cause part or all of the sensor 713 to have a white color instead of a yellow color, which may result in different reflectance values and ultimately a false alarm. In some examples, the undesirable effect of such natural variations on the absolute value of the percent reflectance can be addressed by alternatively examining the rate of change (e.g., slope) of the percent reflectance ratio.
[0154] For example, Fig.35 An example graph 750 of the instantaneous slope of the percent reflectivity ratio of graph 740 is provided. Thus, graph 750 reflects a moving average technique (e.g., with a moving time window of 5 minutes and a sampling rate of 0.42 seconds) applied to the percent reflectivity ratio. The slope is shown as multiplied by 1000, as Fig.34 As shown, the ammonium breakthrough concentration corresponds to a threshold slope (eg, a slope of approximately 5 in this case). As discussed above with reference to graph 740 , such analysis may be performed at one or more processors 729 of the ammonia detector 121 .
[0155] In some examples, natural variations in sensor 713 and undesirable effects of various noise factors have shorter durations in the slope analysis of the percent reflectance ratio (e.g., provided by graph 750) than the duration of the absolute value of the percent reflectance ratio (e.g., provided by graph 740). For example, the temperature-related effects of heating the dialysate to physiological temperature last from about 23 min to about 45 min in graph 740, while in graph 750, such effects begin at about 25 min but begin to diminish shortly thereafter. Events such as fogging of either lens 714, 722 may also last for a shorter period of time in the slope curve than in the curve of the absolute value of the percent reflectance ratio.
[0156] Thus, in some embodiments, certain criteria may be applied to the moving average analysis of the slope of the percent reflectivity ratio in order to determine that the ammonia concentration in the dialysate has reached a certain threshold concentration. For example, such criteria may include the slope remaining equal to or greater than a threshold slope for a minimum time period (e.g., 1 min to approximately 15 min). When such criteria are met and the associated data is sent from the one or more processors 729 to the control system 161, the control system 161 of the fluid regulation system 100 may stop the treatment phase and trigger an alarm implemented via the one or more processors 410 of the control system 161. In some embodiments, the alarm provides an audible notification that alerts the patient or a nearby clinician that a problem has been identified with the treatment phase of the fluid regulation cycle. In some embodiments, the alarm alternatively or additionally provides a visual notification, such as on the display screen 148 (see Figure 1 ) which may indicate that the adsorbent cartridge 303 is exhausted or that the adsorbent cartridge 303 should be replaced.
[0157] For the example analysis provided by graph 750, an ammonia concentration corresponding to an ammonium concentration that meets or exceeds a breakthrough ammonium concentration of about 2 mg / dL can be detected within about 20 minutes of initiating ammonium infusion within the dialysate. In some examples, such behavior was observed over a sample size of three runs, an average ammonium leak detection time of about 12 min, a standard deviation of about 1.05 min, a dialysate flow rate of about 300 mL to about 400 mL, a dialysate temperature of about 36° C. to about 38° C., and a dialysate pH of about 6.5 to about 7.0. After terminating a treatment session due to an ammonium leak, the exhausted sorbent cartridge 303 can be removed and replaced with a new sorbent cartridge 303 to continue treatment.
[0158] Various modifications may be made to any of the above embodiments without departing from the spirit and scope of the above disclosure. For example, while the moving average technique applied to the percent reflectance ratio and the slope of the percent reflectance ratio has been described as including a moving time window of approximately 5 minutes, in other embodiments, an analysis that is otherwise similar to the above analysis may utilize a moving time window of a different period, such as approximately 0.1 minutes or approximately 50 minutes.
[0159] Although sensor 713 has been described as being coated with bromocresol green and malonic acid, in some embodiments, an ammonia sensor that is otherwise substantially similar in construction and function to ammonia sensor 165 may include a sensor coated with one or both of a different acid-base indicator and a different acid.
[0160] Although baffle 715 has been described and illustrated as including base 730 and protrusion 732, in some embodiments, an ammonia sensor that is otherwise substantially similar in construction and function to ammonia sensor 165 may include a baffle having a different profile. For example, Figure 35-37 Baffles 760, 770, 780 are shown, respectively, which define cross-sectional flow areas 764, 774, 784, respectively, having different shapes or sizes than the annular cross-sectional flow area 734, and thus produce different disturbance characteristics in the dialysate fluid flow.
[0161] In some embodiments, an ammonia sensor similar in construction and function to ammonia sensor 165 may include a connector body having a form different from that of connector body 707. For example, Fig.39 An ammonia sensor 790 having such a connector body 797 is shown. The connector body 797 includes input and output flow channels 791, 792 oriented at an angle of about 20 degrees to about 90 degrees to a central axis 791 of the ammonia sensor 790. This configuration of the flow channels 791, 792 is designed to create disturbances in the dialysate fluid flow so that the ammonia sensor 790 does not include baffles. The ammonia sensor 790 additionally includes the membrane 711, the retaining ring 712, the sensor 713, and the lens 714 of the ammonia sensor 165.
[0162] Although the ammonia detection system 100 has been described and illustrated as being used in a dialysate system, in some embodiments, an ammonia detection system similar in construction and function to the ammonia detection system 100 may be used in any type of dialysis system where ammonium or ammonia release is an issue and therefore ammonia detection in the circulating fluid is desired, such as other types of systems not related to dialysis or other types of dialysis systems that do not include a sorbent cartridge.
[0163] Although the ammonia detection system 700 and the adsorbent cartridge 303 have been described and illustrated as stand-alone devices in the fluid conditioning system 100, in some embodiments, a sorbent cartridge that is otherwise similar in construction and functionality to the sorbent cartridge 303 may include or have built-in (e.g., integrated) one or both of an ammonia sensor and an ammonia detector that are functionally and structurally similar in many respects to the ammonia sensor 165 and the ammonia detector 121 of the ammonia detection system 700.
[0164] Although the fluid regulating system 100 has been described and shown as including a pressure transducer 119 (PT1, PT2, PT3, PT4) for regulating pump flow rate, in some embodiments, a fluid regulating system that is otherwise similar in construction and function to the fluid regulating system 100 may alternatively include a flow meter for regulating pump flow rate in place of a pressure transducer. In some embodiments, a fluid regulating system that is otherwise similar in construction and function to the fluid regulating system 100 may not include a pressure transducer or a flow meter, but may instead perform RPM control based on detailed knowledge of the system operation to regulate pump flow rate.
[0165] Although the fluid regulating system 100 has been described and illustrated as including peristaltic pumps 103, 104 (P1, P2, P3, P4), in some embodiments, a fluid regulating system similar in construction and function to the fluid regulating system 100 may alternatively include different types of pumps, such as an impeller pump, a linear displacement pump, a positive displacement pump, or a centrifugal pump.
[0166] Although the fluid regulating system 100 has been described and shown as including one overflow reservoir (e.g., secondary reservoir 305), in some embodiments, a fluid regulating system that is otherwise similar in construction and function to the fluid regulating system 100 may include one or more additional overflow reservoirs. For example, in some embodiments, an additional reservoir may be connected to the fluid circuit 350 upstream of the pump P1 or downstream of the pump P2. In some embodiments, the additional reservoir may have a different capacity than either the reservoir 304 or the reservoir 305, or may have a zero volume capacity. In some embodiments, the reservoir may be permanently connected to the exhaust system.
[0167] Although the heater bag 153 has been described and shown as being disposed downstream of the pump P2 of the fluid regulating system 100, in some embodiments, a fluid regulating system that is otherwise similar in construction and function to the fluid regulating system 100 may include heater bags or other heating elements disposed at various locations along the fluid circuit 350 in order to achieve optimal temperature control of the fluid flowing through the fluid circuit 350. For example, in some embodiments, the heater bag may be located directly downstream of the sorbent cartridge 303 and may be powered based on a signal from the temperature sensor T1 to ensure that the temperature of the dialysis fluid is not high enough to damage the internal components of the sorbent cartridge 303. In some embodiments, the heater bag may be located anywhere along the fluid circuit 350 between valves V1 and V2 as may be advantageous (e.g., to facilitate dissolution of dry chemicals in the supply bags 306, 307, 309).
[0168] Although fluid regulating system 100 has been described as including three-way valves V1-V7, in some embodiments, a fluid regulating system that is otherwise similar in construction and function to fluid regulating system 100 may alternatively include one or more two-way valves to implement the fluid flow path scenarios discussed above.
[0169] Although the operation of the fluid regulation system 100 has been described and illustrated in conjunction with certain flow rates, fluid volumes, temperatures, pressures, and time periods, in some embodiments, the fluid regulation system 100 may also be operated to perform fluid regulation cycles having one or more different flow rates, fluid volumes, temperatures, pressures, and time periods while still functioning to adequately regulate the dialysate for use in a collaborative dialysis system.
[0170] Implementations of the subject matter described in this specification may be implemented as one or more computer program products, i.e., one or more modules of computer program instructions encoded on a tangible program carrier, such as a computer-readable medium, for execution by a processing system or to control the operation of a processing system. The computer-readable medium may be a machine-readable storage device, a machine-readable storage substrate, a memory device, a composition of matter that effects a machine-readable propagated signal, or a combination of one or more of them.
[0171] The term "computer system" may encompass all devices, apparatuses, and machines for processing data, including, for example, a programmable processor, a computer, or multiple processors or computers. In addition to hardware, a processing system may also include code that creates an execution environment for the computer program in question, for example, code constituting processor firmware, a protocol stack, a database management system, an operating system, or a combination of one or more of them.
[0172] A computer program (also referred to as a program, software, software application, script, executable logic, or code) may be written in any form of programming language, including compiled or interpreted languages, declarative or procedural languages, and may be deployed in any form, including as a stand-alone program or as a module, unit, subroutine, or other unit suitable for use in a computing environment. A computer program does not necessarily correspond to a file in a file system. A program may be stored in a portion of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files storing one or more modules, subroutines, or portions of code). A computer program may be deployed to execute on one computer, or on multiple computers located at one site or distributed across multiple sites and interconnected by a communications network.
[0173] Computer-readable media suitable for storing computer program instructions and data include all forms of nonvolatile or volatile memory, media, and storage devices, including, for example, semiconductor memory devices, such as EPROM, EEPROM, and flash memory devices; magnetic disks, such as internal hard disks or removable disks or tapes; magneto-optical disks; and CD-ROM and DVD-ROM disks. The processor and memory may be supplemented by, or incorporated in, special purpose logic circuitry. The components of the system may be interconnected by any form or medium of digital data communication, such as a communication network. Examples of communication networks include local area networks ("LANs") and wide area networks ("WANs"), such as the Internet.
[0174] Other embodiments are within the scope of the following claims.
Claims
1. A spectrum detection system, comprising: a sensor configured to reflect light at a first wavelength associated with the presence of a reference substance on the sensor and configured to reflect light at a second wavelength associated with the presence of a monitored substance on the sensor, the monitored substance flowing from the circulating fluid to the sensor; a connector body that houses the inductor and defines a volume flow direction along a horizontal flow channel of the connector body, wherein a circulating fluid enters and leaves the connector body along the volume flow direction, and the inductor is oriented parallel to the volume flow direction; a flow obstruction positioned within a vertical flow passage of the connector body such that the flow obstruction is oriented perpendicular to the volume flow direction and the sensor, wherein the vertical flow passage is positioned along the horizontal flow passage to cause a circulating fluid to move toward the sensor along a sensing direction perpendicular to the volume flow direction, such that the flow obstruction is configured to generate a disturbance in the circulating fluid to promote the flow of a gas vapor of a monitored substance along the sensing direction toward the sensor; a detector comprising first and second channels for receiving first and second wavelengths of light reflected from the sensor, respectively; and One or more processors are in electronic communication with the detector and are configured to identify an excess condition of the monitored substance relative to the circulating fluid based on a ratio of a second amount of light at the second wavelength received at the detector to a first amount of light at the first wavelength received at the detector.
2. The spectrum detection system according to claim 1, wherein: The sensor includes an acid-base indicator that is sensitive to the pH value of the monitored substance.
3. The spectrum detection system according to claim 1 or 2, wherein: The reference substance is an acidic substance, wherein in an initial state where the reference substance is present on the sensor and the monitored substance is not present on the sensor, the sensor is a first color, wherein in a subsequent state where both the reference substance and the monitored substance are present on the sensor, the sensor is a second color.
4. The spectrum detection system according to claim 1 or 2, wherein: The spectral detection system further comprises one or more lenses arranged to focus the first and second wavelengths of light reflected from the sensor onto the detector.
5. The spectrum detection system according to claim 1 or 2, wherein: The spectral detection system further includes an LED configured to radiate broadband light onto the sensor, wherein the sensor is configured to reflect a first portion of the broadband light as light of a first wavelength and a second portion of the broadband light as light of a second wavelength.
6. The spectrum detection system according to claim 1 or 2, wherein: The spectroscopic detection system also includes a membrane that is permeable to the substance being monitored and is positioned upstream of the sensor.
7. The spectrum detection system according to claim 1 or 2, wherein: The spectral detection system further includes a housing, which supports the sensor and is configured to absorb ambient light.
8. The spectrum detection system according to claim 1 or 2, wherein: The flow obstruction comprises a plate that reduces the cross-sectional flow area within the connector body so as to be able to increase the velocity of the volume flow of the circulating fluid.
9. The spectrum detection system according to claim 8, wherein: The plate includes a base and a protrusion extending from the base.
10. The spectrum detection system according to claim 9, wherein: The spectral detection system also includes a membrane through which the monitored substance can pass and the membrane is positioned upstream of the sensor, wherein the substrate and the vertical flow channel are configured to force the circulating fluid to flow through the substrate and through the flow area with reduced cross-section to increase the diffusion rate of the gas vapor of the monitored substance across the membrane to the sensor.
11. The spectrum detection system according to any one of claims 1, 2, 9 and 10, wherein: The sensor includes a paper material.
12. The spectrum detection system according to any one of claims 1, 2, 9 and 10, wherein: The connector body is configured to be assembled with a fluid line of a fluid cartridge, wherein the connector body is arranged to receive a volume flow of circulating fluid from a device configured to remove a precursor chemical of a monitored substance from the circulating fluid.
13. The spectrum detection system according to any one of claims 1, 2, 9 and 10, wherein: The first amount of light at the first wavelength includes a first percent reflectance of a first color associated with the first wavelength of light, and the second amount of light at the second wavelength includes a second percent reflectance of a second color associated with the second wavelength of light.
14. The spectrum detection system according to any one of claims 1, 2, 9 and 10, wherein: The excess condition includes an increase in the concentration of the monitored substance within the circulating fluid, wherein the increase in the concentration of the monitored substance corresponds to an increase in the concentration of a precursor chemical of the monitored substance to a value equal to or greater than a threshold concentration of the precursor chemical.
15. The spectrum detection system according to any one of claims 1, 2, 9 and 10, wherein: The one or more processors are configured to identify the overdose condition by determining a moving average of the ratio.
16. The spectrum detection system according to claim 15, wherein: The one or more processors are configured to identify the overdose condition by determining a rate of change of the ratio.
17. The spectrum detection system according to claim 16, wherein: The one or more processors are configured to identify the overdose condition by comparing a moving average of the ratio to one or more criteria.
18. The spectrum detection system according to any one of claims 1, 2, 9, 10, 16, and 17, wherein: The one or more processors are configured to transmit data associated with triggering an alarm notification upon identifying the overdose condition.
19. The spectrum detection system according to any one of claims 1, 2, 9, 10, 16, and 17, wherein: The sensor is disposable and the detector is reusable.
20. The spectrum detection system according to any one of claims 1, 2, 9, 10, 16, and 17, wherein: The circulating fluid includes dialysate and the monitored substance includes ammonia.
21. A dialysis system comprising: a sorbent cartridge configured to remove a precursor substance from dialysate circulating through the dialysis system, the precursor substance being a precursor of a monitored substance; and A spectral detection system for identifying an excess condition of a monitored substance relative to a dialysate, the spectral detection system comprising: a sensor configured to reflect light of a first wavelength associated with the presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with the presence of a monitored substance on the sensor, the monitored substance flowing from the dialysate to the sensor, a connector body that accommodates the sensor and defines a volume flow direction along a horizontal flow channel of the connector body, wherein dialysate enters and leaves the connector body along the volume flow direction, the sensor being oriented parallel to the volume flow direction, a flow obstruction positioned within the vertical flow channel of the connector body such that the flow obstruction is oriented perpendicular to the volume flow direction and the sensor, wherein the vertical flow channel is positioned along the horizontal flow channel to move the dialysate toward the sensor along a sensing direction perpendicular to the volume flow direction, such that the flow obstruction is configured to generate a disturbance in the circulating fluid to promote the flow of gas vapor of the monitored substance along the sensing direction toward the sensor, a detector comprising first and second channels for receiving light of first and second wavelengths reflected from the sensor, respectively, and One or more processors in electronic communication with the detector and configured to identify an excess condition of a monitored substance relative to the dialysate based on a ratio of a second amount of light at a second wavelength received at the detector to a first amount of light at the first wavelength received at the detector.
22. A method for detecting a monitored substance in a circulating fluid, the method comprising: flowing a circulating fluid through a horizontal flow passage of a connector body in a volume flow direction, the connector body housing an inductor and the connector body defining a volume flow direction in which the circulating fluid enters and leaves the connector body, the inductor being oriented parallel to the volume flow direction; obstructing the flow of the circulating fluid with a flow obstruction, the flow obstruction being positioned within a vertical flow passage of the connector body, the flow obstruction being oriented perpendicular to the volume flow direction and the inductor, wherein the vertical flow passage is positioned along the horizontal flow passage; Allowing the circulating fluid to flow along the flow obstacle in a sensing direction, the sensing direction being perpendicular to the volume flow direction, so as to generate disturbances in the circulating fluid to promote the gas vapor of the monitored substance to flow toward the sensor along the sensing direction; Allowing the monitored substance to flow from the circulating fluid to the sensor; reflecting light of a first wavelength from the sensor based on the presence of a reference substance on the sensor, and reflecting light of a second wavelength from the sensor based on the presence of a monitored substance on the sensor; receiving light of first and second wavelengths reflected from the sensor in first and second channels of the detector, respectively; as well as At one or more processors in electrical communication with the detector, an excess condition of a monitored substance relative to a circulating fluid is identified based on a ratio of a second amount of light at a second wavelength received at the detector to a first amount of light at a first wavelength received at the detector.
Citation Information
Patent Citations
Solution densitometer and concentration measurement method
JP2003247937A
Ammonia and ammonium sensors
US20030113931A1
Time-Resolved Single-breath Analysis Using Spectroscopic Methods
US20180153439A1
Measurement of analyte concentration
WO2004063393A1
